Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4).

Beach TG, Serrano GE, Kremer T, Canamero M, Dziadek S, Sade H, Derkinderen P, Corbillé AG, Letournel F, Munoz DG, White CL 3rd, Schneider J, Crary JF, Sue LI, Adler CH, Glass MJ, Intorcia AJ, Walker JE, Foroud T, Coffey CS, Ecklund D, Riss H, Goßmann J, König F, Kopil CM, Arnedo V, Riley L, Linder C, Dave KD, Jennings D, Seibyl J, Mollenhauer B, Chahine L; Systemic Synuclein Sampling Study (S4).

J Neuropathol Exp Neurol. 2018 Sep 1;77(9):793-802. doi: 10.1093/jnen/nly056.

2.

Increasing Efficiency of Recruitment in Early Parkinson's Disease Trials: A Case Study Examination of the STEADY-PD III Trial.

Berk S, Greco BL, Biglan K, Kopil CM, Holloway RG, Meunier C, Simuni T.

J Parkinsons Dis. 2017;7(4):685-693. doi: 10.3233/JPD-171199.

3.

The Systemic Synuclein Sampling Study: toward a biomarker for Parkinson's disease.

Visanji NP, Mollenhauer B, Beach TG, Adler CH, Coffey CS, Kopil CM, Dave KD, Foroud T, Chahine L, Jennings D; Systemic Synuclein Sampling Study (S4).

Biomark Med. 2017 Apr;11(4):359-368. doi: 10.2217/bmm-2016-0366. Epub 2017 Mar 29.

4.

Calpain-cleaved type 1 inositol 1,4,5-trisphosphate receptor impairs ER Ca(2+) buffering and causes neurodegeneration in primary cortical neurons.

Kopil CM, Siebert AP, Foskett JK, Neumar RW.

J Neurochem. 2012 Oct;123(1):147-58. doi: 10.1111/j.1471-4159.2012.07859.x. Epub 2012 Aug 14.

5.

Calpain-cleaved type 1 inositol 1,4,5-trisphosphate receptor (InsP(3)R1) has InsP(3)-independent gating and disrupts intracellular Ca(2+) homeostasis.

Kopil CM, Vais H, Cheung KH, Siebert AP, Mak DO, Foskett JK, Neumar RW.

J Biol Chem. 2011 Oct 14;286(41):35998-6010. doi: 10.1074/jbc.M111.254177. Epub 2011 Aug 22.

6.

Impact of therapeutic hypothermia onset and duration on survival, neurologic function, and neurodegeneration after cardiac arrest.

Che D, Li L, Kopil CM, Liu Z, Guo W, Neumar RW.

Crit Care Med. 2011 Jun;39(6):1423-30. doi: 10.1097/CCM.0b013e318212020a.

7.

RNAi targeting micro-calpain increases neuron survival and preserves hippocampal function after global brain ischemia.

Bevers MB, Ingleton LP, Che D, Cole JT, Li L, Da T, Kopil CM, Cohen AS, Neumar RW.

Exp Neurol. 2010 Jul;224(1):170-7. doi: 10.1016/j.expneurol.2010.03.007. Epub 2010 Mar 15.

Supplemental Content

Loading ...
Support Center